
Results
85
High return on equity, past performance and sound balance sheet.
85 companies
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥31.2b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥46.53
7D
1.3%
1Y
46.0%
HBM Holdings
Market Cap: HK$11.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.51
7D
-6.4%
1Y
869.8%
Zealand Pharma
Market Cap: DKK 32.5b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 462.00
7D
-9.8%
1Y
-42.4%
CytomX Therapeutics
Market Cap: US$720.1m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$4.11
7D
5.4%
1Y
287.7%
OSE Immunotherapeutics
Market Cap: €106.8m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€4.76
7D
-4.9%
1Y
-33.6%
Jagsonpal Pharmaceuticals
Market Cap: ₹13.4b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹200.93
7D
0.4%
1Y
-27.0%
Saniona
Market Cap: SEK 2.9b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 21.15
7D
0.2%
1Y
162.7%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م4.0b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م269.83
7D
-1.3%
1Y
130.4%
ADMA Biologics
Market Cap: US$4.6b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$18.83
7D
-5.8%
1Y
6.4%
Niagen Bioscience
Market Cap: US$503.8m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$6.29
7D
-5.1%
1Y
16.3%
PharmaEngine
Market Cap: NT$10.4b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$73.00
7D
1.0%
1Y
-16.5%
Abbott Laboratories (Pakistan)
Market Cap: PK₨102.9b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,051.40
7D
3.2%
1Y
-14.4%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م4.0b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م799.03
7D
-1.8%
1Y
151.4%
Aurinia Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$15.79
7D
2.1%
1Y
73.5%
DreamCIS
Market Cap: ₩128.8b
Provides clinical research services in South Korea.
A223250
₩7,030.00
7D
23.8%
1Y
137.5%
JW Shinyak
Market Cap: ₩114.7b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,938.00
7D
29.3%
1Y
19.8%
Shanghai Xiao Fang PharmaceuticalLtd
Market Cap: CN¥4.5b
Shanghai Xiao Fang Pharmaceutical Co.,Ltd.
603207
CN¥28.42
7D
0%
1Y
6.5%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥16.8b
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
300573
CN¥67.67
7D
-4.7%
1Y
22.0%
Fabtech Technologies
Market Cap: ₹9.9b
Operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally.
FABTECH
₹221.31
7D
-8.4%
1Y
n/a
CORONA Remedies
Market Cap: ₹85.8b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹1,402.90
7D
n/a
1Y
n/a
Société de Therapeutique Marocaine
Market Cap: د.م13.1b
A pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco.
SOT
د.م1,815.00
7D
2.3%
1Y
91.3%
GlaxoSmithKline Pakistan
Market Cap: PK₨122.2b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨383.81
7D
-1.6%
1Y
-1.2%
May & Baker Nigeria
Market Cap: ₦30.7b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦17.80
7D
7.9%
1Y
122.5%
2invest
Market Cap: €64.5m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally.
2INV
€11.70
7D
1.7%
1Y
0.9%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.7b
A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م164.62
7D
-4.8%
1Y
213.5%
BioStem Technologies
Market Cap: US$65.0m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$4.00
7D
-6.3%
1Y
-74.1%
BioSyent
Market Cap: CA$136.3m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.95
7D
1.1%
1Y
2.7%
Ever Supreme Bio Technology
Market Cap: NT$14.4b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$164.00
7D
-1.2%
1Y
5.2%
Puma Biotechnology
Market Cap: US$280.9m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.58
7D
-2.6%
1Y
100.7%
RPG Life Sciences
Market Cap: ₹39.2b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,341.00
7D
1.5%
1Y
3.8%
Central Pharmaceutical No3
Market Cap: ₫1.1t
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.
DP3
₫51,400.00
7D
0.2%
1Y
-11.4%
AstraZeneca Pharma India
Market Cap: ₹225.6b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,074.55
7D
-0.8%
1Y
39.5%
Sanofi Consumer Healthcare India
Market Cap: ₹105.7b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,591.20
7D
0.04%
1Y
-5.1%
Fermenta Biotech
Market Cap: ₹10.3b
Manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally.
506414
₹350.25
7D
16.5%
1Y
-11.4%
Merck
Market Cap: Rp1.5t
Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.
MERK
Rp3,300.00
7D
2.5%
1Y
-7.8%
Cardiogeni
Market Cap: UK£6.7m
A clinical stage biotechnology company, develops heart failure medicines.
CGNI
UK£0.075
7D
0%
1Y
n/a